Triple negative breast cancers (TNBCs) are a specific subtype of epithelial breast tumors that are negative for the protein expression of the estrogen receptor (ER), the progesterone receptor (PR) and lack overexpression/gene amplification of HER2 (hormone epidermal growth factor receptor 2)1. Here, ESR1 is linked to triple-negative breast carcinoma.